Pharmacogenomics

Precision Medication Management

Clinical Testing

Our mission is to serve as a trusted partner to physicians, healthcare professionals and patients by providing quality testing services. Pharmacogenomics is being implemented into routine clinical practice as the medical and pharmaceutical industries move from a one-size-fits-all model to a personalized medicine approach. PGX testing can improve medication management by reducing trial and error prescribing, minimizing adverse drug reactions, improving medication compliance and quality of life, and managing health costs.

PGX In The News

Genemarkers is proud to begin our collaboration with the state of Ohio to advance proactive, scientific strategies to address the opioid crisis

October 3, 2019 – In an effort to fight the opioid epidemic at its source, Ohio Attorney General Dave Yost today announced the launch of two scientific projects aimed at reducing the number of people who succumb to substance use disorder. “While Ohio’s first responders and treatment and recovery experts are fighting a heroic battle to curb opioid-related fatalities, the key to victory is to stop people from becoming addicted in the first place,” Yost said. “The two projects we are launching aim to prevent people from entering the addiction pipeline.” […]

See full press conference

 

Manchester First in U.S. to Launch Pharmacy, Pharmacogenomics Dual Degree

April 26, 2018, Inside Indiana Business – No other pharmacy graduates in the nation will have credentials quite like those from Manchester University, says Director of Pharmacogenomics Education Dr. David Kisor. The small liberal arts school in northern Indiana says it’s the first in the U.S. to offer a dual degree in pharmacy and pharmacogenomics—a relatively new area in healthcare hungry for experts. […]

WSW: What Can Genetics Tells Up About Opioid Effectiveness And Addiction?

April 26, 2018, WMUK Radio – When some people take opioids it addresses their pain, and they have no trouble when it’s time to stop using them. But some people struggle to find the right pain relief, and others end up addicted. A new study being conducted in the Kalamazoo area is searching for the role genetics may play. […]

Study Pioneers Use Of Pharmacogenomic Data In Electronic Health Record

July 18, 2017, The Huffington Post – Nearly 1 out of every 3 American adults has high blood pressure. About 70 percent of them take medication for their condition, but only half have it under control. Why? The answer gets to the heart of precision medicine: Because each one of us has a unique genetic makeup, and we all respond differently to drugs. […]

Following Newborn Pharmacogenomics Program, Inova Launches PGx Testing for Adults

November 17, 2016, Genome Web – After successfully rolling out a program that provided free pharmacogenomics profiling for newborns, the Inova Translational Medicine Institute is now offering PGx analysis for its adult patients. Currently, the PGx test, known as MediMap, is available through Inova’s concierge medicine program, but John Deeken, Inova’s chief operating officer, told GenomeWeb that the institute is working out details to offer it more broadly. […]

Reach out to us today to learn more

Contact Us